What does the Bedside Index for Severity in Acute Pancreatitis (BISAP) score indicate, and which score threshold correlates with severe acute pancreatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

BISAP Score Interpretation and Threshold for Severe Pancreatitis

A BISAP score of ≥2 correlates with severe acute pancreatitis and is the statistically significant cutoff for predicting severity, organ failure, and mortality. 1

What the BISAP Score Measures

The BISAP (Bedside Index for Severity in Acute Pancreatitis) is a simplified prognostic scoring system that assigns one point for each of the following five criteria 1:

  • Blood urea nitrogen level > 8.9 mmol/L (>25 mg/dL)
  • Impaired mental status
  • Systemic inflammatory response syndrome (SIRS) present
  • Age > 60 years
  • Pleural effusion on radiography

The score ranges from 0 to 5 points, calculated within the first 24 hours of admission.

Clinical Significance by Score

BISAP ≥2 is the critical threshold that identifies patients at significantly increased risk for:

  • Severe acute pancreatitis
  • Organ failure (particularly strong predictor with AUC 0.93) 2
  • Mortality 1, 2

The evidence demonstrates that BISAP performs comparably to the more complex APACHE-II score (AUC 0.80 vs 0.80 for severity prediction, 0.86 vs 0.87 for mortality) but is far simpler to calculate and can be applied immediately at admission 2. BISAP outperforms Ranson criteria, CT severity index, C-reactive protein, hematocrit, and BMI for predicting outcomes 1, 2.

Key Advantages in Clinical Practice

The 2019 WSES guidelines specifically recommend BISAP as "one of the most accurate and applicable in everyday clinical practice because of the simplicity and the capability to predict severity, death, and organ failure as well as the APACHE-II (very complex)" 1.

The critical advantage: BISAP identifies patients at increased risk of mortality prior to the onset of organ failure, unlike traditional scoring systems that require 48 hours 1. This early identification window is crucial since 75% of patients requiring intensive care are transferred within the first 72 hours of admission 1.

Practical Application Algorithm

  1. Calculate BISAP within 24 hours of admission for all acute pancreatitis patients
  2. BISAP < 2: Lower risk; standard ward management typically appropriate
  3. BISAP ≥ 2: High risk; strongly consider:
    • ICU or intermediate care unit admission 1
    • Contrast-enhanced CT after 72 hours to assess pancreatic necrosis
    • Aggressive fluid resuscitation
    • Close monitoring for organ failure development

Important Caveats

While BISAP ≥2 has high sensitivity and excellent negative predictive value (100% in some studies 3), no scoring system is perfect. Some patients with BISAP <2 will still develop complications, and many with BISAP ≥2 will have uncomplicated recovery 1. The score should guide—not replace—ongoing clinical assessment. Recent evidence suggests BISAP maintains strong independent predictive value (OR 2.10 for mortality) even when controlling for age, comorbidities, and other clinical factors 3.

The cutoff of ≥2 has been validated across multiple international cohorts and remains consistent whether predicting severity, organ failure, or mortality, making it a robust single-threshold tool 4, 5.

Related Questions

What are the urgent surgical indications in acute pancreatitis?
How should I manage an acute pancreatitis patient with normal serum amylase and lipase who has severe abdominal pain unresponsive to tramadol?
In a 26-year-old woman with acute abdominal pain and imaging‑confirmed acute pancreatitis, what further diagnostic work‑up and initial medical management are indicated?
What does a BISAP (Bedside Index for Severity in Acute Pancreatitis) score of 3 indicate and how should the patient be managed?
In a 55-year-old woman with no past medical history who presents with a 10-hour history of severe epigastric pain radiating to the back, stable vital signs, and a soft, tender abdomen, what is the appropriate diagnostic workup and initial management for suspected acute pancreatitis?
What transdermal estradiol options are available for a symptomatic perimenopausal woman with an intact uterus and no contraindications to estrogen?
In a symptomatic perimenopausal woman with an intact uterus and no estrogen contraindications, what progesterone-only transdermal patches are available for menopausal hormone therapy?
What is acidity (acidosis), what are its causes, how does bicarbonate (HCO₃⁻) buffer hydrogen ions, and how is diabetic ketoacidosis (DKA) diagnosed?
What is the recommended dosing and monitoring for vitamin D3 (cholecalciferol) and vitamin K2 (menaquinone‑7) supplementation?
What is clomipramine, including its mechanism of action, clinical indications, dosing guidelines, and contraindications?
What are the best supplements for insulin resistance?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.